AI-designed drugs, exemplified by rentosertib’s Phase IIa success, and personalized gene editing breakthroughs like KJ Muldoon’s recovery are proving that advanced biotechnologies are delivering ...

In 2026, the biotech landscape has undergone a seismic shift, moving beyond the hype cycles of the past decade into a phase of tangible, life-saving applications. With the first wave of CRISPR-based ...

Plants have been cloning themselves for millions of years. Strawberries send out runners, potatoes sprout new shoots, and ...

Spread the loveThe recent announcement from a multinational research team regarding a novel CRISPR gene therapy has sparked excitement and hope among millions affected by genetic blindness. In a ...

Following a reimbursement deal with Vertex, people with SCD in Germany will now have greater access to the gene-editing ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while ...

An international research team from academia and industry publishes new findings on the nuclease Cas12a2 in the journal Nature ...

A new kind of CRISPR that destroys cells rather than gene editing them has shown potential for killing sick cells while leaving healthy cells untouched. The technology has largely been tested in cells ...

CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Bank of ...

When activated by its target, the newly characterized molecule rips the genome apart, a lethal move that researchers can ...

Intellia Therapeutics (NTLA) is a clinical-stage biotech firm working on CRISPR-based treatments that try to edit genes ...